Global Oncology & Cancer Drugs Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Oncology & Cancer Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Oncology & Cancer Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Oncology & Cancer Drugs market. Oncology & Cancer Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oncology & Cancer Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oncology & Cancer Drugs market.
Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified. When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Oncology & Cancer Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Oncology & Cancer Drugs market. It may include historical data, market segmentation by Type (e.g., Chemotherapy, Targeted Therapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oncology & Cancer Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Oncology & Cancer Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Oncology & Cancer Drugs industry. This include advancements in Oncology & Cancer Drugs technology, Oncology & Cancer Drugs new entrants, Oncology & Cancer Drugs new investment, and other innovations that are shaping the future of Oncology & Cancer Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oncology & Cancer Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Oncology & Cancer Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oncology & Cancer Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oncology & Cancer Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oncology & Cancer Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oncology & Cancer Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oncology & Cancer Drugs market.
Market Segmentation:
Oncology & Cancer Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Oncology & Cancer Drugs market?
What factors are driving Oncology & Cancer Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oncology & Cancer Drugs market opportunities vary by end market size?
How does Oncology & Cancer Drugs break out type, application?
According to our LPI (LP Information) latest study, the global Oncology & Cancer Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Oncology & Cancer Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Oncology & Cancer Drugs market. Oncology & Cancer Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oncology & Cancer Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oncology & Cancer Drugs market.
Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified. When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Oncology & Cancer Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Oncology & Cancer Drugs market. It may include historical data, market segmentation by Type (e.g., Chemotherapy, Targeted Therapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oncology & Cancer Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Oncology & Cancer Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Oncology & Cancer Drugs industry. This include advancements in Oncology & Cancer Drugs technology, Oncology & Cancer Drugs new entrants, Oncology & Cancer Drugs new investment, and other innovations that are shaping the future of Oncology & Cancer Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oncology & Cancer Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Oncology & Cancer Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oncology & Cancer Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oncology & Cancer Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oncology & Cancer Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oncology & Cancer Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oncology & Cancer Drugs market.
Market Segmentation:
Oncology & Cancer Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Chemotherapy
- Targeted Therapy
- Immunotherapy (Biologic Therapy)
- Hormonal Therapy
- Others
- Blood Cancer
- Breast Cancer
- Gastrointestinal Cancer
- Prostate Cancer
- Respiratory/Lung Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Celgene
- Novartis
- Bristol-Myers Squibb
- Johnson & Johnson
- Merck & Co.
- AstraZeneca
- Pfizer
- Amgen
- Eli Lilly
- AbbVie
- Takeda
- Astellas
- Ipsen
- Sanofi
- Bayer
- Biogen Idec
- Teva
- Otsuka
- Eisai
- Merck KGaA
- Gilead Sciences
What is the 10-year outlook for the global Oncology & Cancer Drugs market?
What factors are driving Oncology & Cancer Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oncology & Cancer Drugs market opportunities vary by end market size?
How does Oncology & Cancer Drugs break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology & Cancer Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Oncology & Cancer Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Oncology & Cancer Drugs by Country/Region, 2019, 2023 & 2030
2.2 Oncology & Cancer Drugs Segment by Type
2.2.1 Chemotherapy
2.2.2 Targeted Therapy
2.2.3 Immunotherapy (Biologic Therapy)
2.2.4 Hormonal Therapy
2.2.5 Others
2.3 Oncology & Cancer Drugs Sales by Type
2.3.1 Global Oncology & Cancer Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global Oncology & Cancer Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global Oncology & Cancer Drugs Sale Price by Type (2019-2024)
2.4 Oncology & Cancer Drugs Segment by Application
2.4.1 Blood Cancer
2.4.2 Breast Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Respiratory/Lung Cancer
2.4.6 Others
2.5 Oncology & Cancer Drugs Sales by Application
2.5.1 Global Oncology & Cancer Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global Oncology & Cancer Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global Oncology & Cancer Drugs Sale Price by Application (2019-2024)
3 GLOBAL ONCOLOGY & CANCER DRUGS BY COMPANY
3.1 Global Oncology & Cancer Drugs Breakdown Data by Company
3.1.1 Global Oncology & Cancer Drugs Annual Sales by Company (2019-2024)
3.1.2 Global Oncology & Cancer Drugs Sales Market Share by Company (2019-2024)
3.2 Global Oncology & Cancer Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global Oncology & Cancer Drugs Revenue by Company (2019-2024)
3.2.2 Global Oncology & Cancer Drugs Revenue Market Share by Company (2019-2024)
3.3 Global Oncology & Cancer Drugs Sale Price by Company
3.4 Key Manufacturers Oncology & Cancer Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oncology & Cancer Drugs Product Location Distribution
3.4.2 Players Oncology & Cancer Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ONCOLOGY & CANCER DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Oncology & Cancer Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global Oncology & Cancer Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Oncology & Cancer Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Oncology & Cancer Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global Oncology & Cancer Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global Oncology & Cancer Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oncology & Cancer Drugs Sales Growth
4.4 APAC Oncology & Cancer Drugs Sales Growth
4.5 Europe Oncology & Cancer Drugs Sales Growth
4.6 Middle East & Africa Oncology & Cancer Drugs Sales Growth
5 AMERICAS
5.1 Americas Oncology & Cancer Drugs Sales by Country
5.1.1 Americas Oncology & Cancer Drugs Sales by Country (2019-2024)
5.1.2 Americas Oncology & Cancer Drugs Revenue by Country (2019-2024)
5.2 Americas Oncology & Cancer Drugs Sales by Type
5.3 Americas Oncology & Cancer Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology & Cancer Drugs Sales by Region
6.1.1 APAC Oncology & Cancer Drugs Sales by Region (2019-2024)
6.1.2 APAC Oncology & Cancer Drugs Revenue by Region (2019-2024)
6.2 APAC Oncology & Cancer Drugs Sales by Type
6.3 APAC Oncology & Cancer Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oncology & Cancer Drugs by Country
7.1.1 Europe Oncology & Cancer Drugs Sales by Country (2019-2024)
7.1.2 Europe Oncology & Cancer Drugs Revenue by Country (2019-2024)
7.2 Europe Oncology & Cancer Drugs Sales by Type
7.3 Europe Oncology & Cancer Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology & Cancer Drugs by Country
8.1.1 Middle East & Africa Oncology & Cancer Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa Oncology & Cancer Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa Oncology & Cancer Drugs Sales by Type
8.3 Middle East & Africa Oncology & Cancer Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oncology & Cancer Drugs
10.3 Manufacturing Process Analysis of Oncology & Cancer Drugs
10.4 Industry Chain Structure of Oncology & Cancer Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oncology & Cancer Drugs Distributors
11.3 Oncology & Cancer Drugs Customer
12 WORLD FORECAST REVIEW FOR ONCOLOGY & CANCER DRUGS BY GEOGRAPHIC REGION
12.1 Global Oncology & Cancer Drugs Market Size Forecast by Region
12.1.1 Global Oncology & Cancer Drugs Forecast by Region (2025-2030)
12.1.2 Global Oncology & Cancer Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oncology & Cancer Drugs Forecast by Type
12.7 Global Oncology & Cancer Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Oncology & Cancer Drugs Product Portfolios and Specifications
13.1.3 Roche Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Celgene
13.2.1 Celgene Company Information
13.2.2 Celgene Oncology & Cancer Drugs Product Portfolios and Specifications
13.2.3 Celgene Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Celgene Main Business Overview
13.2.5 Celgene Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Oncology & Cancer Drugs Product Portfolios and Specifications
13.3.3 Novartis Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Bristol-Myers Squibb
13.4.1 Bristol-Myers Squibb Company Information
13.4.2 Bristol-Myers Squibb Oncology & Cancer Drugs Product Portfolios and Specifications
13.4.3 Bristol-Myers Squibb Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Bristol-Myers Squibb Main Business Overview
13.4.5 Bristol-Myers Squibb Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Oncology & Cancer Drugs Product Portfolios and Specifications
13.5.3 Johnson & Johnson Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Merck & Co.
13.6.1 Merck & Co. Company Information
13.6.2 Merck & Co. Oncology & Cancer Drugs Product Portfolios and Specifications
13.6.3 Merck & Co. Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Merck & Co. Main Business Overview
13.6.5 Merck & Co. Latest Developments
13.7 AstraZeneca
13.7.1 AstraZeneca Company Information
13.7.2 AstraZeneca Oncology & Cancer Drugs Product Portfolios and Specifications
13.7.3 AstraZeneca Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 AstraZeneca Main Business Overview
13.7.5 AstraZeneca Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Oncology & Cancer Drugs Product Portfolios and Specifications
13.8.3 Pfizer Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Amgen
13.9.1 Amgen Company Information
13.9.2 Amgen Oncology & Cancer Drugs Product Portfolios and Specifications
13.9.3 Amgen Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Amgen Main Business Overview
13.9.5 Amgen Latest Developments
13.10 Eli Lilly
13.10.1 Eli Lilly Company Information
13.10.2 Eli Lilly Oncology & Cancer Drugs Product Portfolios and Specifications
13.10.3 Eli Lilly Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Eli Lilly Main Business Overview
13.10.5 Eli Lilly Latest Developments
13.11 AbbVie
13.11.1 AbbVie Company Information
13.11.2 AbbVie Oncology & Cancer Drugs Product Portfolios and Specifications
13.11.3 AbbVie Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 AbbVie Main Business Overview
13.11.5 AbbVie Latest Developments
13.12 Takeda
13.12.1 Takeda Company Information
13.12.2 Takeda Oncology & Cancer Drugs Product Portfolios and Specifications
13.12.3 Takeda Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Takeda Main Business Overview
13.12.5 Takeda Latest Developments
13.13 Astellas
13.13.1 Astellas Company Information
13.13.2 Astellas Oncology & Cancer Drugs Product Portfolios and Specifications
13.13.3 Astellas Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Astellas Main Business Overview
13.13.5 Astellas Latest Developments
13.14 Ipsen
13.14.1 Ipsen Company Information
13.14.2 Ipsen Oncology & Cancer Drugs Product Portfolios and Specifications
13.14.3 Ipsen Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Ipsen Main Business Overview
13.14.5 Ipsen Latest Developments
13.15 Sanofi
13.15.1 Sanofi Company Information
13.15.2 Sanofi Oncology & Cancer Drugs Product Portfolios and Specifications
13.15.3 Sanofi Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Sanofi Main Business Overview
13.15.5 Sanofi Latest Developments
13.16 Bayer
13.16.1 Bayer Company Information
13.16.2 Bayer Oncology & Cancer Drugs Product Portfolios and Specifications
13.16.3 Bayer Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Bayer Main Business Overview
13.16.5 Bayer Latest Developments
13.17 Biogen Idec
13.17.1 Biogen Idec Company Information
13.17.2 Biogen Idec Oncology & Cancer Drugs Product Portfolios and Specifications
13.17.3 Biogen Idec Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Biogen Idec Main Business Overview
13.17.5 Biogen Idec Latest Developments
13.18 Teva
13.18.1 Teva Company Information
13.18.2 Teva Oncology & Cancer Drugs Product Portfolios and Specifications
13.18.3 Teva Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Teva Main Business Overview
13.18.5 Teva Latest Developments
13.19 Otsuka
13.19.1 Otsuka Company Information
13.19.2 Otsuka Oncology & Cancer Drugs Product Portfolios and Specifications
13.19.3 Otsuka Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Otsuka Main Business Overview
13.19.5 Otsuka Latest Developments
13.20 Eisai
13.20.1 Eisai Company Information
13.20.2 Eisai Oncology & Cancer Drugs Product Portfolios and Specifications
13.20.3 Eisai Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Eisai Main Business Overview
13.20.5 Eisai Latest Developments
13.21 Merck KGaA
13.21.1 Merck KGaA Company Information
13.21.2 Merck KGaA Oncology & Cancer Drugs Product Portfolios and Specifications
13.21.3 Merck KGaA Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 Merck KGaA Main Business Overview
13.21.5 Merck KGaA Latest Developments
13.22 Gilead Sciences
13.22.1 Gilead Sciences Company Information
13.22.2 Gilead Sciences Oncology & Cancer Drugs Product Portfolios and Specifications
13.22.3 Gilead Sciences Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 Gilead Sciences Main Business Overview
13.22.5 Gilead Sciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology & Cancer Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Oncology & Cancer Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Oncology & Cancer Drugs by Country/Region, 2019, 2023 & 2030
2.2 Oncology & Cancer Drugs Segment by Type
2.2.1 Chemotherapy
2.2.2 Targeted Therapy
2.2.3 Immunotherapy (Biologic Therapy)
2.2.4 Hormonal Therapy
2.2.5 Others
2.3 Oncology & Cancer Drugs Sales by Type
2.3.1 Global Oncology & Cancer Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global Oncology & Cancer Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global Oncology & Cancer Drugs Sale Price by Type (2019-2024)
2.4 Oncology & Cancer Drugs Segment by Application
2.4.1 Blood Cancer
2.4.2 Breast Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Respiratory/Lung Cancer
2.4.6 Others
2.5 Oncology & Cancer Drugs Sales by Application
2.5.1 Global Oncology & Cancer Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global Oncology & Cancer Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global Oncology & Cancer Drugs Sale Price by Application (2019-2024)
3 GLOBAL ONCOLOGY & CANCER DRUGS BY COMPANY
3.1 Global Oncology & Cancer Drugs Breakdown Data by Company
3.1.1 Global Oncology & Cancer Drugs Annual Sales by Company (2019-2024)
3.1.2 Global Oncology & Cancer Drugs Sales Market Share by Company (2019-2024)
3.2 Global Oncology & Cancer Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global Oncology & Cancer Drugs Revenue by Company (2019-2024)
3.2.2 Global Oncology & Cancer Drugs Revenue Market Share by Company (2019-2024)
3.3 Global Oncology & Cancer Drugs Sale Price by Company
3.4 Key Manufacturers Oncology & Cancer Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oncology & Cancer Drugs Product Location Distribution
3.4.2 Players Oncology & Cancer Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ONCOLOGY & CANCER DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Oncology & Cancer Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global Oncology & Cancer Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Oncology & Cancer Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Oncology & Cancer Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global Oncology & Cancer Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global Oncology & Cancer Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oncology & Cancer Drugs Sales Growth
4.4 APAC Oncology & Cancer Drugs Sales Growth
4.5 Europe Oncology & Cancer Drugs Sales Growth
4.6 Middle East & Africa Oncology & Cancer Drugs Sales Growth
5 AMERICAS
5.1 Americas Oncology & Cancer Drugs Sales by Country
5.1.1 Americas Oncology & Cancer Drugs Sales by Country (2019-2024)
5.1.2 Americas Oncology & Cancer Drugs Revenue by Country (2019-2024)
5.2 Americas Oncology & Cancer Drugs Sales by Type
5.3 Americas Oncology & Cancer Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology & Cancer Drugs Sales by Region
6.1.1 APAC Oncology & Cancer Drugs Sales by Region (2019-2024)
6.1.2 APAC Oncology & Cancer Drugs Revenue by Region (2019-2024)
6.2 APAC Oncology & Cancer Drugs Sales by Type
6.3 APAC Oncology & Cancer Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oncology & Cancer Drugs by Country
7.1.1 Europe Oncology & Cancer Drugs Sales by Country (2019-2024)
7.1.2 Europe Oncology & Cancer Drugs Revenue by Country (2019-2024)
7.2 Europe Oncology & Cancer Drugs Sales by Type
7.3 Europe Oncology & Cancer Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology & Cancer Drugs by Country
8.1.1 Middle East & Africa Oncology & Cancer Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa Oncology & Cancer Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa Oncology & Cancer Drugs Sales by Type
8.3 Middle East & Africa Oncology & Cancer Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oncology & Cancer Drugs
10.3 Manufacturing Process Analysis of Oncology & Cancer Drugs
10.4 Industry Chain Structure of Oncology & Cancer Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oncology & Cancer Drugs Distributors
11.3 Oncology & Cancer Drugs Customer
12 WORLD FORECAST REVIEW FOR ONCOLOGY & CANCER DRUGS BY GEOGRAPHIC REGION
12.1 Global Oncology & Cancer Drugs Market Size Forecast by Region
12.1.1 Global Oncology & Cancer Drugs Forecast by Region (2025-2030)
12.1.2 Global Oncology & Cancer Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oncology & Cancer Drugs Forecast by Type
12.7 Global Oncology & Cancer Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Oncology & Cancer Drugs Product Portfolios and Specifications
13.1.3 Roche Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Celgene
13.2.1 Celgene Company Information
13.2.2 Celgene Oncology & Cancer Drugs Product Portfolios and Specifications
13.2.3 Celgene Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Celgene Main Business Overview
13.2.5 Celgene Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Oncology & Cancer Drugs Product Portfolios and Specifications
13.3.3 Novartis Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Bristol-Myers Squibb
13.4.1 Bristol-Myers Squibb Company Information
13.4.2 Bristol-Myers Squibb Oncology & Cancer Drugs Product Portfolios and Specifications
13.4.3 Bristol-Myers Squibb Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Bristol-Myers Squibb Main Business Overview
13.4.5 Bristol-Myers Squibb Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Oncology & Cancer Drugs Product Portfolios and Specifications
13.5.3 Johnson & Johnson Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Merck & Co.
13.6.1 Merck & Co. Company Information
13.6.2 Merck & Co. Oncology & Cancer Drugs Product Portfolios and Specifications
13.6.3 Merck & Co. Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Merck & Co. Main Business Overview
13.6.5 Merck & Co. Latest Developments
13.7 AstraZeneca
13.7.1 AstraZeneca Company Information
13.7.2 AstraZeneca Oncology & Cancer Drugs Product Portfolios and Specifications
13.7.3 AstraZeneca Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 AstraZeneca Main Business Overview
13.7.5 AstraZeneca Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Oncology & Cancer Drugs Product Portfolios and Specifications
13.8.3 Pfizer Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Amgen
13.9.1 Amgen Company Information
13.9.2 Amgen Oncology & Cancer Drugs Product Portfolios and Specifications
13.9.3 Amgen Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Amgen Main Business Overview
13.9.5 Amgen Latest Developments
13.10 Eli Lilly
13.10.1 Eli Lilly Company Information
13.10.2 Eli Lilly Oncology & Cancer Drugs Product Portfolios and Specifications
13.10.3 Eli Lilly Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Eli Lilly Main Business Overview
13.10.5 Eli Lilly Latest Developments
13.11 AbbVie
13.11.1 AbbVie Company Information
13.11.2 AbbVie Oncology & Cancer Drugs Product Portfolios and Specifications
13.11.3 AbbVie Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 AbbVie Main Business Overview
13.11.5 AbbVie Latest Developments
13.12 Takeda
13.12.1 Takeda Company Information
13.12.2 Takeda Oncology & Cancer Drugs Product Portfolios and Specifications
13.12.3 Takeda Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Takeda Main Business Overview
13.12.5 Takeda Latest Developments
13.13 Astellas
13.13.1 Astellas Company Information
13.13.2 Astellas Oncology & Cancer Drugs Product Portfolios and Specifications
13.13.3 Astellas Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Astellas Main Business Overview
13.13.5 Astellas Latest Developments
13.14 Ipsen
13.14.1 Ipsen Company Information
13.14.2 Ipsen Oncology & Cancer Drugs Product Portfolios and Specifications
13.14.3 Ipsen Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Ipsen Main Business Overview
13.14.5 Ipsen Latest Developments
13.15 Sanofi
13.15.1 Sanofi Company Information
13.15.2 Sanofi Oncology & Cancer Drugs Product Portfolios and Specifications
13.15.3 Sanofi Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Sanofi Main Business Overview
13.15.5 Sanofi Latest Developments
13.16 Bayer
13.16.1 Bayer Company Information
13.16.2 Bayer Oncology & Cancer Drugs Product Portfolios and Specifications
13.16.3 Bayer Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Bayer Main Business Overview
13.16.5 Bayer Latest Developments
13.17 Biogen Idec
13.17.1 Biogen Idec Company Information
13.17.2 Biogen Idec Oncology & Cancer Drugs Product Portfolios and Specifications
13.17.3 Biogen Idec Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Biogen Idec Main Business Overview
13.17.5 Biogen Idec Latest Developments
13.18 Teva
13.18.1 Teva Company Information
13.18.2 Teva Oncology & Cancer Drugs Product Portfolios and Specifications
13.18.3 Teva Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Teva Main Business Overview
13.18.5 Teva Latest Developments
13.19 Otsuka
13.19.1 Otsuka Company Information
13.19.2 Otsuka Oncology & Cancer Drugs Product Portfolios and Specifications
13.19.3 Otsuka Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Otsuka Main Business Overview
13.19.5 Otsuka Latest Developments
13.20 Eisai
13.20.1 Eisai Company Information
13.20.2 Eisai Oncology & Cancer Drugs Product Portfolios and Specifications
13.20.3 Eisai Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Eisai Main Business Overview
13.20.5 Eisai Latest Developments
13.21 Merck KGaA
13.21.1 Merck KGaA Company Information
13.21.2 Merck KGaA Oncology & Cancer Drugs Product Portfolios and Specifications
13.21.3 Merck KGaA Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 Merck KGaA Main Business Overview
13.21.5 Merck KGaA Latest Developments
13.22 Gilead Sciences
13.22.1 Gilead Sciences Company Information
13.22.2 Gilead Sciences Oncology & Cancer Drugs Product Portfolios and Specifications
13.22.3 Gilead Sciences Oncology & Cancer Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 Gilead Sciences Main Business Overview
13.22.5 Gilead Sciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oncology & Cancer Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Oncology & Cancer Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Chemotherapy
Table 4. Major Players of Targeted Therapy
Table 5. Major Players of Immunotherapy (Biologic Therapy)
Table 6. Major Players of Hormonal Therapy
Table 7. Major Players of Others
Table 8. Global Oncology & Cancer Drugs Sales by Type (2019-2024) & (K Units)
Table 9. Global Oncology & Cancer Drugs Sales Market Share by Type (2019-2024)
Table 10. Global Oncology & Cancer Drugs Revenue by Type (2019-2024) & ($ million)
Table 11. Global Oncology & Cancer Drugs Revenue Market Share by Type (2019-2024)
Table 12. Global Oncology & Cancer Drugs Sale Price by Type (2019-2024) & (US$/Unit)
Table 13. Global Oncology & Cancer Drugs Sales by Application (2019-2024) & (K Units)
Table 14. Global Oncology & Cancer Drugs Sales Market Share by Application (2019-2024)
Table 15. Global Oncology & Cancer Drugs Revenue by Application (2019-2024)
Table 16. Global Oncology & Cancer Drugs Revenue Market Share by Application (2019-2024)
Table 17. Global Oncology & Cancer Drugs Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global Oncology & Cancer Drugs Sales by Company (2019-2024) & (K Units)
Table 19. Global Oncology & Cancer Drugs Sales Market Share by Company (2019-2024)
Table 20. Global Oncology & Cancer Drugs Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Oncology & Cancer Drugs Revenue Market Share by Company (2019-2024)
Table 22. Global Oncology & Cancer Drugs Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers Oncology & Cancer Drugs Producing Area Distribution and Sales Area
Table 24. Players Oncology & Cancer Drugs Products Offered
Table 25. Oncology & Cancer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Oncology & Cancer Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Oncology & Cancer Drugs Sales Market Share Geographic Region (2019-2024)
Table 30. Global Oncology & Cancer Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Oncology & Cancer Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Oncology & Cancer Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Oncology & Cancer Drugs Sales Market Share by Country/Region (2019-2024)
Table 34. Global Oncology & Cancer Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Oncology & Cancer Drugs Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Oncology & Cancer Drugs Sales by Country (2019-2024) & (K Units)
Table 37. Americas Oncology & Cancer Drugs Sales Market Share by Country (2019-2024)
Table 38. Americas Oncology & Cancer Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Oncology & Cancer Drugs Revenue Market Share by Country (2019-2024)
Table 40. Americas Oncology & Cancer Drugs Sales by Type (2019-2024) & (K Units)
Table 41. Americas Oncology & Cancer Drugs Sales by Application (2019-2024) & (K Units)
Table 42. APAC Oncology & Cancer Drugs Sales by Region (2019-2024) & (K Units)
Table 43. APAC Oncology & Cancer Drugs Sales Market Share by Region (2019-2024)
Table 44. APAC Oncology & Cancer Drugs Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Oncology & Cancer Drugs Revenue Market Share by Region (2019-2024)
Table 46. APAC Oncology & Cancer Drugs Sales by Type (2019-2024) & (K Units)
Table 47. APAC Oncology & Cancer Drugs Sales by Application (2019-2024) & (K Units)
Table 48. Europe Oncology & Cancer Drugs Sales by Country (2019-2024) & (K Units)
Table 49. Europe Oncology & Cancer Drugs Sales Market Share by Country (2019-2024)
Table 50. Europe Oncology & Cancer Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Oncology & Cancer Drugs Revenue Market Share by Country (2019-2024)
Table 52. Europe Oncology & Cancer Drugs Sales by Type (2019-2024) & (K Units)
Table 53. Europe Oncology & Cancer Drugs Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa Oncology & Cancer Drugs Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa Oncology & Cancer Drugs Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Oncology & Cancer Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Oncology & Cancer Drugs Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Oncology & Cancer Drugs Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa Oncology & Cancer Drugs Sales by Application (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Oncology & Cancer Drugs
Table 61. Key Market Challenges & Risks of Oncology & Cancer Drugs
Table 62. Key Industry Trends of Oncology & Cancer Drugs
Table 63. Oncology & Cancer Drugs Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Oncology & Cancer Drugs Distributors List
Table 66. Oncology & Cancer Drugs Customer List
Table 67. Global Oncology & Cancer Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global Oncology & Cancer Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Oncology & Cancer Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas Oncology & Cancer Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Oncology & Cancer Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC Oncology & Cancer Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Oncology & Cancer Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe Oncology & Cancer Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Oncology & Cancer Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa Oncology & Cancer Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Oncology & Cancer Drugs Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global Oncology & Cancer Drugs Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Oncology & Cancer Drugs Sales Forecast by Application (2025-2030) & (K Units)
Table 80. Global Oncology & Cancer Drugs Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Roche Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 82. Roche Oncology & Cancer Drugs Product Portfolios and Specifications
Table 83. Roche Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 84. Roche Main Business
Table 85. Roche Latest Developments
Table 86. Celgene Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 87. Celgene Oncology & Cancer Drugs Product Portfolios and Specifications
Table 88. Celgene Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 89. Celgene Main Business
Table 90. Celgene Latest Developments
Table 91. Novartis Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 92. Novartis Oncology & Cancer Drugs Product Portfolios and Specifications
Table 93. Novartis Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 94. Novartis Main Business
Table 95. Novartis Latest Developments
Table 96. Bristol-Myers Squibb Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. Bristol-Myers Squibb Oncology & Cancer Drugs Product Portfolios and Specifications
Table 98. Bristol-Myers Squibb Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 99. Bristol-Myers Squibb Main Business
Table 100. Bristol-Myers Squibb Latest Developments
Table 101. Johnson & Johnson Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. Johnson & Johnson Oncology & Cancer Drugs Product Portfolios and Specifications
Table 103. Johnson & Johnson Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 104. Johnson & Johnson Main Business
Table 105. Johnson & Johnson Latest Developments
Table 106. Merck & Co. Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. Merck & Co. Oncology & Cancer Drugs Product Portfolios and Specifications
Table 108. Merck & Co. Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 109. Merck & Co. Main Business
Table 110. Merck & Co. Latest Developments
Table 111. AstraZeneca Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 112. AstraZeneca Oncology & Cancer Drugs Product Portfolios and Specifications
Table 113. AstraZeneca Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 114. AstraZeneca Main Business
Table 115. AstraZeneca Latest Developments
Table 116. Pfizer Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 117. Pfizer Oncology & Cancer Drugs Product Portfolios and Specifications
Table 118. Pfizer Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 119. Pfizer Main Business
Table 120. Pfizer Latest Developments
Table 121. Amgen Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 122. Amgen Oncology & Cancer Drugs Product Portfolios and Specifications
Table 123. Amgen Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 124. Amgen Main Business
Table 125. Amgen Latest Developments
Table 126. Eli Lilly Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 127. Eli Lilly Oncology & Cancer Drugs Product Portfolios and Specifications
Table 128. Eli Lilly Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 129. Eli Lilly Main Business
Table 130. Eli Lilly Latest Developments
Table 131. AbbVie Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 132. AbbVie Oncology & Cancer Drugs Product Portfolios and Specifications
Table 133. AbbVie Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 134. AbbVie Main Business
Table 135. AbbVie Latest Developments
Table 136. Takeda Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 137. Takeda Oncology & Cancer Drugs Product Portfolios and Specifications
Table 138. Takeda Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 139. Takeda Main Business
Table 140. Takeda Latest Developments
Table 141. Astellas Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 142. Astellas Oncology & Cancer Drugs Product Portfolios and Specifications
Table 143. Astellas Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 144. Astellas Main Business
Table 145. Astellas Latest Developments
Table 146. Ipsen Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 147. Ipsen Oncology & Cancer Drugs Product Portfolios and Specifications
Table 148. Ipsen Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 149. Ipsen Main Business
Table 150. Ipsen Latest Developments
Table 151. Sanofi Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 152. Sanofi Oncology & Cancer Drugs Product Portfolios and Specifications
Table 153. Sanofi Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 154. Sanofi Main Business
Table 155. Sanofi Latest Developments
Table 156. Bayer Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 157. Bayer Oncology & Cancer Drugs Product Portfolios and Specifications
Table 158. Bayer Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 159. Bayer Main Business
Table 160. Bayer Latest Developments
Table 161. Biogen Idec Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 162. Biogen Idec Oncology & Cancer Drugs Product Portfolios and Specifications
Table 163. Biogen Idec Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 164. Biogen Idec Main Business
Table 165. Biogen Idec Latest Developments
Table 166. Teva Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 167. Teva Oncology & Cancer Drugs Product Portfolios and Specifications
Table 168. Teva Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 169. Teva Main Business
Table 170. Teva Latest Developments
Table 171. Otsuka Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 172. Otsuka Oncology & Cancer Drugs Product Portfolios and Specifications
Table 173. Otsuka Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 174. Otsuka Main Business
Table 175. Otsuka Latest Developments
Table 176. Eisai Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 177. Eisai Oncology & Cancer Drugs Product Portfolios and Specifications
Table 178. Eisai Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 179. Eisai Main Business
Table 180. Eisai Latest Developments
Table 181. Merck KGaA Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 182. Merck KGaA Oncology & Cancer Drugs Product Portfolios and Specifications
Table 183. Merck KGaA Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 184. Merck KGaA Main Business
Table 185. Merck KGaA Latest Developments
Table 186. Gilead Sciences Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 187. Gilead Sciences Oncology & Cancer Drugs Product Portfolios and Specifications
Table 188. Gilead Sciences Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 189. Gilead Sciences Main Business
Table 190. Gilead Sciences Latest Developments
Table 1. Oncology & Cancer Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Oncology & Cancer Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Chemotherapy
Table 4. Major Players of Targeted Therapy
Table 5. Major Players of Immunotherapy (Biologic Therapy)
Table 6. Major Players of Hormonal Therapy
Table 7. Major Players of Others
Table 8. Global Oncology & Cancer Drugs Sales by Type (2019-2024) & (K Units)
Table 9. Global Oncology & Cancer Drugs Sales Market Share by Type (2019-2024)
Table 10. Global Oncology & Cancer Drugs Revenue by Type (2019-2024) & ($ million)
Table 11. Global Oncology & Cancer Drugs Revenue Market Share by Type (2019-2024)
Table 12. Global Oncology & Cancer Drugs Sale Price by Type (2019-2024) & (US$/Unit)
Table 13. Global Oncology & Cancer Drugs Sales by Application (2019-2024) & (K Units)
Table 14. Global Oncology & Cancer Drugs Sales Market Share by Application (2019-2024)
Table 15. Global Oncology & Cancer Drugs Revenue by Application (2019-2024)
Table 16. Global Oncology & Cancer Drugs Revenue Market Share by Application (2019-2024)
Table 17. Global Oncology & Cancer Drugs Sale Price by Application (2019-2024) & (US$/Unit)
Table 18. Global Oncology & Cancer Drugs Sales by Company (2019-2024) & (K Units)
Table 19. Global Oncology & Cancer Drugs Sales Market Share by Company (2019-2024)
Table 20. Global Oncology & Cancer Drugs Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Oncology & Cancer Drugs Revenue Market Share by Company (2019-2024)
Table 22. Global Oncology & Cancer Drugs Sale Price by Company (2019-2024) & (US$/Unit)
Table 23. Key Manufacturers Oncology & Cancer Drugs Producing Area Distribution and Sales Area
Table 24. Players Oncology & Cancer Drugs Products Offered
Table 25. Oncology & Cancer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Oncology & Cancer Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Oncology & Cancer Drugs Sales Market Share Geographic Region (2019-2024)
Table 30. Global Oncology & Cancer Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Oncology & Cancer Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Oncology & Cancer Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Oncology & Cancer Drugs Sales Market Share by Country/Region (2019-2024)
Table 34. Global Oncology & Cancer Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Oncology & Cancer Drugs Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Oncology & Cancer Drugs Sales by Country (2019-2024) & (K Units)
Table 37. Americas Oncology & Cancer Drugs Sales Market Share by Country (2019-2024)
Table 38. Americas Oncology & Cancer Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Oncology & Cancer Drugs Revenue Market Share by Country (2019-2024)
Table 40. Americas Oncology & Cancer Drugs Sales by Type (2019-2024) & (K Units)
Table 41. Americas Oncology & Cancer Drugs Sales by Application (2019-2024) & (K Units)
Table 42. APAC Oncology & Cancer Drugs Sales by Region (2019-2024) & (K Units)
Table 43. APAC Oncology & Cancer Drugs Sales Market Share by Region (2019-2024)
Table 44. APAC Oncology & Cancer Drugs Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Oncology & Cancer Drugs Revenue Market Share by Region (2019-2024)
Table 46. APAC Oncology & Cancer Drugs Sales by Type (2019-2024) & (K Units)
Table 47. APAC Oncology & Cancer Drugs Sales by Application (2019-2024) & (K Units)
Table 48. Europe Oncology & Cancer Drugs Sales by Country (2019-2024) & (K Units)
Table 49. Europe Oncology & Cancer Drugs Sales Market Share by Country (2019-2024)
Table 50. Europe Oncology & Cancer Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Oncology & Cancer Drugs Revenue Market Share by Country (2019-2024)
Table 52. Europe Oncology & Cancer Drugs Sales by Type (2019-2024) & (K Units)
Table 53. Europe Oncology & Cancer Drugs Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa Oncology & Cancer Drugs Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa Oncology & Cancer Drugs Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Oncology & Cancer Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Oncology & Cancer Drugs Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Oncology & Cancer Drugs Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa Oncology & Cancer Drugs Sales by Application (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Oncology & Cancer Drugs
Table 61. Key Market Challenges & Risks of Oncology & Cancer Drugs
Table 62. Key Industry Trends of Oncology & Cancer Drugs
Table 63. Oncology & Cancer Drugs Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Oncology & Cancer Drugs Distributors List
Table 66. Oncology & Cancer Drugs Customer List
Table 67. Global Oncology & Cancer Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global Oncology & Cancer Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Oncology & Cancer Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas Oncology & Cancer Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Oncology & Cancer Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC Oncology & Cancer Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Oncology & Cancer Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe Oncology & Cancer Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Oncology & Cancer Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa Oncology & Cancer Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Oncology & Cancer Drugs Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global Oncology & Cancer Drugs Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Oncology & Cancer Drugs Sales Forecast by Application (2025-2030) & (K Units)
Table 80. Global Oncology & Cancer Drugs Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Roche Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 82. Roche Oncology & Cancer Drugs Product Portfolios and Specifications
Table 83. Roche Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 84. Roche Main Business
Table 85. Roche Latest Developments
Table 86. Celgene Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 87. Celgene Oncology & Cancer Drugs Product Portfolios and Specifications
Table 88. Celgene Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 89. Celgene Main Business
Table 90. Celgene Latest Developments
Table 91. Novartis Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 92. Novartis Oncology & Cancer Drugs Product Portfolios and Specifications
Table 93. Novartis Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 94. Novartis Main Business
Table 95. Novartis Latest Developments
Table 96. Bristol-Myers Squibb Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. Bristol-Myers Squibb Oncology & Cancer Drugs Product Portfolios and Specifications
Table 98. Bristol-Myers Squibb Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 99. Bristol-Myers Squibb Main Business
Table 100. Bristol-Myers Squibb Latest Developments
Table 101. Johnson & Johnson Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. Johnson & Johnson Oncology & Cancer Drugs Product Portfolios and Specifications
Table 103. Johnson & Johnson Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 104. Johnson & Johnson Main Business
Table 105. Johnson & Johnson Latest Developments
Table 106. Merck & Co. Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. Merck & Co. Oncology & Cancer Drugs Product Portfolios and Specifications
Table 108. Merck & Co. Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 109. Merck & Co. Main Business
Table 110. Merck & Co. Latest Developments
Table 111. AstraZeneca Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 112. AstraZeneca Oncology & Cancer Drugs Product Portfolios and Specifications
Table 113. AstraZeneca Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 114. AstraZeneca Main Business
Table 115. AstraZeneca Latest Developments
Table 116. Pfizer Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 117. Pfizer Oncology & Cancer Drugs Product Portfolios and Specifications
Table 118. Pfizer Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 119. Pfizer Main Business
Table 120. Pfizer Latest Developments
Table 121. Amgen Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 122. Amgen Oncology & Cancer Drugs Product Portfolios and Specifications
Table 123. Amgen Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 124. Amgen Main Business
Table 125. Amgen Latest Developments
Table 126. Eli Lilly Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 127. Eli Lilly Oncology & Cancer Drugs Product Portfolios and Specifications
Table 128. Eli Lilly Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 129. Eli Lilly Main Business
Table 130. Eli Lilly Latest Developments
Table 131. AbbVie Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 132. AbbVie Oncology & Cancer Drugs Product Portfolios and Specifications
Table 133. AbbVie Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 134. AbbVie Main Business
Table 135. AbbVie Latest Developments
Table 136. Takeda Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 137. Takeda Oncology & Cancer Drugs Product Portfolios and Specifications
Table 138. Takeda Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 139. Takeda Main Business
Table 140. Takeda Latest Developments
Table 141. Astellas Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 142. Astellas Oncology & Cancer Drugs Product Portfolios and Specifications
Table 143. Astellas Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 144. Astellas Main Business
Table 145. Astellas Latest Developments
Table 146. Ipsen Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 147. Ipsen Oncology & Cancer Drugs Product Portfolios and Specifications
Table 148. Ipsen Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 149. Ipsen Main Business
Table 150. Ipsen Latest Developments
Table 151. Sanofi Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 152. Sanofi Oncology & Cancer Drugs Product Portfolios and Specifications
Table 153. Sanofi Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 154. Sanofi Main Business
Table 155. Sanofi Latest Developments
Table 156. Bayer Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 157. Bayer Oncology & Cancer Drugs Product Portfolios and Specifications
Table 158. Bayer Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 159. Bayer Main Business
Table 160. Bayer Latest Developments
Table 161. Biogen Idec Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 162. Biogen Idec Oncology & Cancer Drugs Product Portfolios and Specifications
Table 163. Biogen Idec Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 164. Biogen Idec Main Business
Table 165. Biogen Idec Latest Developments
Table 166. Teva Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 167. Teva Oncology & Cancer Drugs Product Portfolios and Specifications
Table 168. Teva Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 169. Teva Main Business
Table 170. Teva Latest Developments
Table 171. Otsuka Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 172. Otsuka Oncology & Cancer Drugs Product Portfolios and Specifications
Table 173. Otsuka Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 174. Otsuka Main Business
Table 175. Otsuka Latest Developments
Table 176. Eisai Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 177. Eisai Oncology & Cancer Drugs Product Portfolios and Specifications
Table 178. Eisai Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 179. Eisai Main Business
Table 180. Eisai Latest Developments
Table 181. Merck KGaA Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 182. Merck KGaA Oncology & Cancer Drugs Product Portfolios and Specifications
Table 183. Merck KGaA Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 184. Merck KGaA Main Business
Table 185. Merck KGaA Latest Developments
Table 186. Gilead Sciences Basic Information, Oncology & Cancer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 187. Gilead Sciences Oncology & Cancer Drugs Product Portfolios and Specifications
Table 188. Gilead Sciences Oncology & Cancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 189. Gilead Sciences Main Business
Table 190. Gilead Sciences Latest Developments
LIST OF FIGURES
Figure 1. Picture of Oncology & Cancer Drugs
Figure 2. Oncology & Cancer Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oncology & Cancer Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Oncology & Cancer Drugs Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Oncology & Cancer Drugs Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Chemotherapy
Figure 10. Product Picture of Targeted Therapy
Figure 11. Product Picture of Immunotherapy (Biologic Therapy)
Figure 12. Product Picture of Hormonal Therapy
Figure 13. Product Picture of Others
Figure 14. Global Oncology & Cancer Drugs Sales Market Share by Type in 2023
Figure 15. Global Oncology & Cancer Drugs Revenue Market Share by Type (2019-2024)
Figure 16. Oncology & Cancer Drugs Consumed in Blood Cancer
Figure 17. Global Oncology & Cancer Drugs Market: Blood Cancer (2019-2024) & (K Units)
Figure 18. Oncology & Cancer Drugs Consumed in Breast Cancer
Figure 19. Global Oncology & Cancer Drugs Market: Breast Cancer (2019-2024) & (K Units)
Figure 20. Oncology & Cancer Drugs Consumed in Gastrointestinal Cancer
Figure 21. Global Oncology & Cancer Drugs Market: Gastrointestinal Cancer (2019-2024) & (K Units)
Figure 22. Oncology & Cancer Drugs Consumed in Prostate Cancer
Figure 23. Global Oncology & Cancer Drugs Market: Prostate Cancer (2019-2024) & (K Units)
Figure 24. Oncology & Cancer Drugs Consumed in Respiratory/Lung Cancer
Figure 25. Global Oncology & Cancer Drugs Market: Respiratory/Lung Cancer (2019-2024) & (K Units)
Figure 26. Oncology & Cancer Drugs Consumed in Others
Figure 27. Global Oncology & Cancer Drugs Market: Others (2019-2024) & (K Units)
Figure 28. Global Oncology & Cancer Drugs Sales Market Share by Application (2023)
Figure 29. Global Oncology & Cancer Drugs Revenue Market Share by Application in 2023
Figure 30. Oncology & Cancer Drugs Sales Market by Company in 2023 (K Units)
Figure 31. Global Oncology & Cancer Drugs Sales Market Share by Company in 2023
Figure 32. Oncology & Cancer Drugs Revenue Market by Company in 2023 ($ Million)
Figure 33. Global Oncology & Cancer Drugs Revenue Market Share by Company in 2023
Figure 34. Global Oncology & Cancer Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 35. Global Oncology & Cancer Drugs Revenue Market Share by Geographic Region in 2023
Figure 36. Americas Oncology & Cancer Drugs Sales 2019-2024 (K Units)
Figure 37. Americas Oncology & Cancer Drugs Revenue 2019-2024 ($ Millions)
Figure 38. APAC Oncology & Cancer Drugs Sales 2019-2024 (K Units)
Figure 39. APAC Oncology & Cancer Drugs Revenue 2019-2024 ($ Millions)
Figure 40. Europe Oncology & Cancer Drugs Sales 2019-2024 (K Units)
Figure 41. Europe Oncology & Cancer Drugs Revenue 2019-2024 ($ Millions)
Figure 42. Middle East & Africa Oncology & Cancer Drugs Sales 2019-2024 (K Units)
Figure 43. Middle East & Africa Oncology & Cancer Drugs Revenue 2019-2024 ($ Millions)
Figure 44. Americas Oncology & Cancer Drugs Sales Market Share by Country in 2023
Figure 45. Americas Oncology & Cancer Drugs Revenue Market Share by Country in 2023
Figure 46. Americas Oncology & Cancer Drugs Sales Market Share by Type (2019-2024)
Figure 47. Americas Oncology & Cancer Drugs Sales Market Share by Application (2019-2024)
Figure 48. United States Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 49. Canada Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 50. Mexico Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 51. Brazil Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 52. APAC Oncology & Cancer Drugs Sales Market Share by Region in 2023
Figure 53. APAC Oncology & Cancer Drugs Revenue Market Share by Regions in 2023
Figure 54. APAC Oncology & Cancer Drugs Sales Market Share by Type (2019-2024)
Figure 55. APAC Oncology & Cancer Drugs Sales Market Share by Application (2019-2024)
Figure 56. China Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 57. Japan Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 58. South Korea Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 59. Southeast Asia Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 60. India Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 61. Australia Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 62. China Taiwan Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 63. Europe Oncology & Cancer Drugs Sales Market Share by Country in 2023
Figure 64. Europe Oncology & Cancer Drugs Revenue Market Share by Country in 2023
Figure 65. Europe Oncology & Cancer Drugs Sales Market Share by Type (2019-2024)
Figure 66. Europe Oncology & Cancer Drugs Sales Market Share by Application (2019-2024)
Figure 67. Germany Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 68. France Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 69. UK Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 70. Italy Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 71. Russia Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 72. Middle East & Africa Oncology & Cancer Drugs Sales Market Share by Country in 2023
Figure 73. Middle East & Africa Oncology & Cancer Drugs Revenue Market Share by Country in 2023
Figure 74. Middle East & Africa Oncology & Cancer Drugs Sales Market Share by Type (2019-2024)
Figure 75. Middle East & Africa Oncology & Cancer Drugs Sales Market Share by Application (2019-2024)
Figure 76. Egypt Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 77. South Africa Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 78. Israel Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 79. Turkey Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 80. GCC Country Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 81. Manufacturing Cost Structure Analysis of Oncology & Cancer Drugs in 2023
Figure 82. Manufacturing Process Analysis of Oncology & Cancer Drugs
Figure 83. Industry Chain Structure of Oncology & Cancer Drugs
Figure 84. Channels of Distribution
Figure 85. Global Oncology & Cancer Drugs Sales Market Forecast by Region (2025-2030)
Figure 86. Global Oncology & Cancer Drugs Revenue Market Share Forecast by Region (2025-2030)
Figure 87. Global Oncology & Cancer Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 88. Global Oncology & Cancer Drugs Revenue Market Share Forecast by Type (2025-2030)
Figure 89. Global Oncology & Cancer Drugs Sales Market Share Forecast by Application (2025-2030)
Figure 90. Global Oncology & Cancer Drugs Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Oncology & Cancer Drugs
Figure 2. Oncology & Cancer Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oncology & Cancer Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Oncology & Cancer Drugs Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Oncology & Cancer Drugs Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Chemotherapy
Figure 10. Product Picture of Targeted Therapy
Figure 11. Product Picture of Immunotherapy (Biologic Therapy)
Figure 12. Product Picture of Hormonal Therapy
Figure 13. Product Picture of Others
Figure 14. Global Oncology & Cancer Drugs Sales Market Share by Type in 2023
Figure 15. Global Oncology & Cancer Drugs Revenue Market Share by Type (2019-2024)
Figure 16. Oncology & Cancer Drugs Consumed in Blood Cancer
Figure 17. Global Oncology & Cancer Drugs Market: Blood Cancer (2019-2024) & (K Units)
Figure 18. Oncology & Cancer Drugs Consumed in Breast Cancer
Figure 19. Global Oncology & Cancer Drugs Market: Breast Cancer (2019-2024) & (K Units)
Figure 20. Oncology & Cancer Drugs Consumed in Gastrointestinal Cancer
Figure 21. Global Oncology & Cancer Drugs Market: Gastrointestinal Cancer (2019-2024) & (K Units)
Figure 22. Oncology & Cancer Drugs Consumed in Prostate Cancer
Figure 23. Global Oncology & Cancer Drugs Market: Prostate Cancer (2019-2024) & (K Units)
Figure 24. Oncology & Cancer Drugs Consumed in Respiratory/Lung Cancer
Figure 25. Global Oncology & Cancer Drugs Market: Respiratory/Lung Cancer (2019-2024) & (K Units)
Figure 26. Oncology & Cancer Drugs Consumed in Others
Figure 27. Global Oncology & Cancer Drugs Market: Others (2019-2024) & (K Units)
Figure 28. Global Oncology & Cancer Drugs Sales Market Share by Application (2023)
Figure 29. Global Oncology & Cancer Drugs Revenue Market Share by Application in 2023
Figure 30. Oncology & Cancer Drugs Sales Market by Company in 2023 (K Units)
Figure 31. Global Oncology & Cancer Drugs Sales Market Share by Company in 2023
Figure 32. Oncology & Cancer Drugs Revenue Market by Company in 2023 ($ Million)
Figure 33. Global Oncology & Cancer Drugs Revenue Market Share by Company in 2023
Figure 34. Global Oncology & Cancer Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 35. Global Oncology & Cancer Drugs Revenue Market Share by Geographic Region in 2023
Figure 36. Americas Oncology & Cancer Drugs Sales 2019-2024 (K Units)
Figure 37. Americas Oncology & Cancer Drugs Revenue 2019-2024 ($ Millions)
Figure 38. APAC Oncology & Cancer Drugs Sales 2019-2024 (K Units)
Figure 39. APAC Oncology & Cancer Drugs Revenue 2019-2024 ($ Millions)
Figure 40. Europe Oncology & Cancer Drugs Sales 2019-2024 (K Units)
Figure 41. Europe Oncology & Cancer Drugs Revenue 2019-2024 ($ Millions)
Figure 42. Middle East & Africa Oncology & Cancer Drugs Sales 2019-2024 (K Units)
Figure 43. Middle East & Africa Oncology & Cancer Drugs Revenue 2019-2024 ($ Millions)
Figure 44. Americas Oncology & Cancer Drugs Sales Market Share by Country in 2023
Figure 45. Americas Oncology & Cancer Drugs Revenue Market Share by Country in 2023
Figure 46. Americas Oncology & Cancer Drugs Sales Market Share by Type (2019-2024)
Figure 47. Americas Oncology & Cancer Drugs Sales Market Share by Application (2019-2024)
Figure 48. United States Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 49. Canada Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 50. Mexico Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 51. Brazil Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 52. APAC Oncology & Cancer Drugs Sales Market Share by Region in 2023
Figure 53. APAC Oncology & Cancer Drugs Revenue Market Share by Regions in 2023
Figure 54. APAC Oncology & Cancer Drugs Sales Market Share by Type (2019-2024)
Figure 55. APAC Oncology & Cancer Drugs Sales Market Share by Application (2019-2024)
Figure 56. China Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 57. Japan Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 58. South Korea Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 59. Southeast Asia Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 60. India Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 61. Australia Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 62. China Taiwan Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 63. Europe Oncology & Cancer Drugs Sales Market Share by Country in 2023
Figure 64. Europe Oncology & Cancer Drugs Revenue Market Share by Country in 2023
Figure 65. Europe Oncology & Cancer Drugs Sales Market Share by Type (2019-2024)
Figure 66. Europe Oncology & Cancer Drugs Sales Market Share by Application (2019-2024)
Figure 67. Germany Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 68. France Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 69. UK Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 70. Italy Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 71. Russia Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 72. Middle East & Africa Oncology & Cancer Drugs Sales Market Share by Country in 2023
Figure 73. Middle East & Africa Oncology & Cancer Drugs Revenue Market Share by Country in 2023
Figure 74. Middle East & Africa Oncology & Cancer Drugs Sales Market Share by Type (2019-2024)
Figure 75. Middle East & Africa Oncology & Cancer Drugs Sales Market Share by Application (2019-2024)
Figure 76. Egypt Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 77. South Africa Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 78. Israel Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 79. Turkey Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 80. GCC Country Oncology & Cancer Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 81. Manufacturing Cost Structure Analysis of Oncology & Cancer Drugs in 2023
Figure 82. Manufacturing Process Analysis of Oncology & Cancer Drugs
Figure 83. Industry Chain Structure of Oncology & Cancer Drugs
Figure 84. Channels of Distribution
Figure 85. Global Oncology & Cancer Drugs Sales Market Forecast by Region (2025-2030)
Figure 86. Global Oncology & Cancer Drugs Revenue Market Share Forecast by Region (2025-2030)
Figure 87. Global Oncology & Cancer Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 88. Global Oncology & Cancer Drugs Revenue Market Share Forecast by Type (2025-2030)
Figure 89. Global Oncology & Cancer Drugs Sales Market Share Forecast by Application (2025-2030)
Figure 90. Global Oncology & Cancer Drugs Revenue Market Share Forecast by Application (2025-2030)
